SHOULDER INNOVATIONS, INC.
For the period ended Jun 30, 2025. Filed Sep 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Sep 9, 2025
SI$21.46+4.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets (unaudited)
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents | $27,054 | $6,123 |
| Marketable securities | 12,581 | 8,921 |
| Trade accounts receivable, net of allowance for credit losses | 6,886 | 5,122 |
| Inventories, net | 17,081 | 13,955 |
| Prepaid expenses | 691 | 431 |
| Other current assets | 4,618 | 573 |
| Total Current Assets | 68,911 | 35,125 |
| Property and equipment, net | 8,506 | 7,487 |
| Operating lease right-of-use asset | 162 | 68 |
| Intangible assets, net | 250 | 400 |
| Total Assets | 77,829 | 43,080 |
| Liabilities, Convertible Preferred Stock, and Stockholders’ Deficit | ||
| Current Liabilities | ||
| Accounts payable ($673 and $813 to related parties, respectively) | 6,042 | 4,860 |
| Current operating lease obligations | 82 | 47 |
| Accrued liabilities | 6,370 | 2,740 |
| Total Current Liabilities | 12,494 | 7,647 |
| Long-Term Liabilities | ||
| Preferred stock warrant liability | 1,967 | 970 |
| Long-term debt | 14,784 | 14,658 |
| Other long-term liabilities | 84 | 25 |
| Total Long-Term Liabilities | 16,835 | 15,653 |
| Total Liabilities | 29,329 | 23,300 |
| Commitments and contingencies (note 8) | ||
| Convertible Preferred Stock | ||
| Series Seed, $0.001 par value, 16,840,400 shares authorized, and 16,840,400 and 15,851,401 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 1,420 | 1,337 |
| Series A, $0.001 par value, 22,399,370 shares authorized, issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 5,600 | 5,600 |
| Series B, $0.001 par value, 6,913,964 shares authorized, and 6,663,964 and 5,913,964 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 2,897 | 2,200 |
| Series C, $0.001 par value, 50,116,284 shares authorized, issued, and outstanding as of June 30, 2025 and December 31, 2024, respectively | 21,550 | 21,550 |
| Series D, $0.001 par value, 83,403,626 shares authorized, and 80,909,169 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 43,788 | 43,788 |
| Series E, $0.001 par value, 58,774,332 shares authorized, and 58,774,312 and 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 51,445 | — |
| Total Convertible Preferred Stock | 126,700 | 74,475 |
Condensed Balance Sheets
| Stockholders’ Deficit | ||
|---|---|---|
| Common stock, $0.001 par value, 280,986,575 shares authorized, and 2,839,173 issued and outstanding as of June 30, 2025 and 212,366,763 shares authorized and 83,882 issued and outstanding as of December 31, 2024 | 1 | 1 |
| Additional paid-in capital | 2,616 | 2,148 |
| Accumulated deficit | (80,899) | (57,041) |
| Accumulated other comprehensive income | 82 | 197 |
| Total Stockholders’ Deficit | (78,200) | (54,695) |
| Total Liabilities, Convertible Preferred Stock, and Stockholders’ Deficit | $77,829 | $43,080 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.